E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/26/2006 in the Prospect News Biotech Daily.

Alcon at peer perform by Bear Stearns

Alcon Inc. was rated at peer perform by Bear Stearns analyst Milton Hsu due in part to the lack of what the analyst believes are positive short-term catalysts leading to multiple expansion. Despite the fact that the company may top its revised 2006 earnings-per-share guidance, there may not be enough potential upside to drive the stock higher in any meaningful way. Bear Stearns forecasts the stock trading at between $93 and $105 over the next several quarters. Shares of the Hunenberg, Switzerland, pharmaceutical company were up $1.83, or 1.88%, at $99.26 on volume of 3,347,400 shares versus the three-month running average of 1,059,840 shares. (NYSE: ACL)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.